4/A

OWNERSHIP DOCUMENT

Company: NRX Pharmaceuticals, Inc.
Filed: June 2, 2022
Period of Report: June 1, 2022
Accession Number: 0000921895-22-001874

View Document ↗ View on SEC.gov ↗